Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Cost of Revenue (2024 - 2025)

Upstream Bio (UPB) has 2 years of Cost of Revenue data on record, last reported at $2.5 million in Q3 2025.

  • For Q3 2025, Cost of Revenue rose 16.66% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $17.4 million, changed N/A, while the annual FY2024 figure was $6.6 million, 95.08% up from the prior year.
  • Cost of Revenue reached $2.5 million in Q3 2025 per UPB's latest filing, down from $10.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $10.0 million in Q2 2025 and bottomed at $351000.0 in Q1 2024.